Delivery Order SPE2DR25D3103-SPE2DR26F9K07
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,773.18 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 15, 2025, with an ultimate completion date of August 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,523.02 for Protonix 40 mg suspension (30-count) with an ultimate completion date of July 21, 2025. This firm fixed-price contract, awarded on July 18, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $3,345.81 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30-count). This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of January 5, 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran...
- This delivery order, valued at $6,319.00, was awarded to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Protonix 40 mg suspension (30-count units). The contract is funded by the Defense Logistics Agency under the Department of Defense and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is...
- The Defense Logistics Agency awarded a delivery order valued at $5,591.48 to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30 units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order represents a non-competitive procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Protonix 40 mg suspension (30-count) under a firm fixed-price contract. The award, issued on October 28, 2025, carries a ceiling value of $1,156.78 and is scheduled for completion by October 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,972.12 delivery order is for Protonix 40 mg suspension, a pharmaceutical product used by the Department of Defense. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC) with DLA,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The order is for PROTONIX DR 40 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $1,760.02 and a performance period through March 18, 2024. AmerisourceBergen Drug Corp is the prime contractor and this order falls under an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued...
- This federal contract award is for the delivery of PROTONIX 40 MG SUSPENSION 30S to the Defense Logistics Agency, a defense agency. The $6,674.67 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract has an ultimate completion date of July 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of PROTONIX 40 MG SUSPENSION 30S, a prescription medication. The contract has a ceiling value of $2,742.80 and a completion date of July 23, 2024. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous other federal contracts by the DLA and other...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9K07Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,464.45 to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Protonix 40 mg suspension in 30-unit quantities. This is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and represents a non-competitive, non-set-aside award. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a broad portfolio of medications and medical supplies to support military healthcare programs and other federal agencies. The company's extensive federal contract history demonstrates consistent capability in fulfilling both small-value and large-volume pharmaceutical procurement requirements through competitively awarded vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 11/27/25 |